Globalization
-

Silicon Valley is increasingly invested in clean technologies and is already looked upon as a global leader in new technological development. As happens with most new technologies in their infancy, Silicon Valley's focus is currently on component manufacturing. However, a difference from earlier technology cycles is the upfront impact of globalization, especially the emergence of China and India as providers of skilled labor and large markets.  Accordingly, the globalization of cleantech could follow some well-trodden paths and some new ones:

  1. As manufacturing gets modularized, firms such as Applied Materials might shift component work to East Asia. Some of this is already happening.
  2. System integration and other service provision might increasingly be provided by the large Indian system integrators. As of 2009, however, there is little evidence of this happening.
  3. Firms in Europe and East Asia have been investing in cleantech for some time now, and might participate in technological leadership. 

In each case, we are interested in exploring the time-frame and the driving forces.   These will typically be outcomes of a mix of regulatory, domestic market and skills issues.

The conference, the fifth in the annual series on the Globalization of Services, will likely host about 20 academics and 40 corporates, as with past events. 

Presentations are planned by firms in Silicon Valley in the fields of component manufacturing, systems integration and service provision; by overseas service providers on how outsourcing in these areas improves outcomes in terms of strategic direction, efficiency, cost-savings and accountability; by OEMs on supply-chain linkages with service outsourcers; and by venture capitalists and consultants on how their work helps the process of outsourcing cleantech services.

Registration is required for this event ($30 by Dec. 4, $45 late) and includes continental breakfast, lunch and free parking. Use the RSVP link at the top of the page to register.

Information on the previous Globalization of Services conference, including presentations, is available here.

8:00Registration and Breakfast
8:30Welcome and Objectives
Rafiq Dossani
8:35-9:15

Keynote: Fostering the Green Economy--The Case of California
Ricardo Martinez Garcia, Deputy Secretary, California Environmental Protection Agency

9:15-10:30Panel: Cleantech technology trends
Marc Hoffman, Glacier Bay | Ajit Nazre, Kleiner Perkins | Swaminathan Venkataraman, Standard & Poor's
Lead discussant: Professor Dimitris Assimakopoulos, Grenoble School of Management, France
10:30-10:45Break
10:45-12:30Panel: Software and services
Chris Farinacci, Hara.com | Matt Denesuk, IBM | Sai Gundavelli, Solix
Lead discussant: Professor Petri Rouvinen, ETLA Finland
12:30-1:45Lunch
1:30-3:30Panel: Manufacturing
Charles Consorte, Zeptor | Chris D'Couto, Neah | Marc Hoffman, Glacier Bay
Lead discussant: Professor Margot Gerritsen, Energy Resources Engineering, Stanford University
3:30-3:50Break
3:50-5:30Panel: Globalization
Rafiq Dossani, Stanford | Joe Muscat, Ernst and Young | Bob Nelson, Akin Gump | Sean Wang, ITRI | Tomoya Yamashiki, Toray Industries (America) Inc.
Lead discussant: Henry Rowen, Stanford University

 


This conference is the 5th annual "Globalization of Services" conference, made possible through the generosity and efforts of ETLA, The Research Institute of the Finnish Economy, the University of Colorado, Denver and Wipro.

Image
Image
Wipro logo

Gundavelli Solix
Download pdf

Bechtel Conference Center

Conferences
Date Label
Paragraphs
PrescribingCultures front cover

Pharmaceutical policies are interlinked globally and at the same time deeply rooted in local culture. Prescribing Cultures examines how pharmaceuticals and their regulation play an important and often contentious role in the health systems of the Asia-Pacific.

The first section of this timely book analyzes pharmaceutical policy in China, Korea, Japan, Thailand, Taiwan, Australia, and India. The second section focuses on two cross-cutting themes: differences in "prescribing cultures" and physician dispensing; and the challenge of balancing access to drugs with incentives for innovation.

The book's contributors discuss important issues for U.S. policy. These include such hot-button topics as drug imports from Asia, regulation of global supply chains to assure drug safety and quality, new legislation to encourage development of drugs for neglected diseases, and the impact that decisions about pricing, regulation, and bilateral trade agreements have on access to medicines at home and abroad. In Prescribing Cultures, pharmaceutical policy reveals the economic trade-offs, political compromises, and historical trajectories that shape health systems.

Prescribing Cultures also illustrates how cultural legacies shape and are shaped by the forces of globalization, and thus will be of interest to students and scholars well beyond the confines of health policy.

Desk, examination, or review copies can be requested through Stanford University Press

All Publications button
1
Publication Type
Books
Publication Date
Authors
Karen Eggleston
Book Publisher
Shorenstein APARC
-

Pharmaceutical policies are interlinked globally, yet deeply rooted in local culture. The newly published book Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, edited by Karen Eggleston, examines how pharmaceuticals and their regulation play an important and often contentious role in the health systems of the Asia-Pacific.

In this colloquium, contributors to Prescribing Cultures discuss how the book analyzes pharmaceutical policy in China, Korea, Japan, Thailand, Taiwan, Australia, and India, focusing on two cross-cutting themes: differences in “prescribing cultures” and physician dispensing; and the challenge of balancing access to drugs with incentives for innovation.

As Michael Reich of Harvard University says in his Forward to Prescribing Cultures,

“The pharmaceutical sector…promises great benefits and also poses enormous risks.… Conflicts abound over public policies, industry strategies, payment mechanisms, professional associations, and dispensing practices—to name just a few of the regional controversies covered in this excellent book.

The tension between emphasizing innovation versus access -- a topic of hot debate on today’s global health policy agenda -- is examined in several chapters…

This book makes a special contribution to our understanding of the pharmaceutical sector in China… Globalization is galloping forward, with Chinese producers pushing the pace at breakneck speed. More and more, our safety depends on China’s ability to get its regulatory act together…”

The colloquium features presentations by Naoko Tomita (Keio University), Anita Wagner (Harvard University), and Karen Eggleston (Stanford FSI Shorenstein Asia-Pacific Research Center). They will give specific examples of how pharmaceutical policy serves as a window into the economic tradeoffs, political compromises, and historical trajectories that shape health systems, as well as how cultural legacies shape and are shaped by the forces of globalization.

Oksenberg Conference Room

Anita Wagner Speaker Harvard University
Naoko Tomita Speaker Keio University

Shorenstein APARC
Stanford University
Encina Hall E301
Stanford, CA 94305-6055

(650) 723-9072 (650) 723-6530
0
Senior Fellow at the Freeman Spogli Institute for International Studies
Center Fellow at the Center for Health Policy and the Center for Primary Care and Outcomes Research
Faculty Research Fellow of the National Bureau of Economic Research
Faculty Affiliate at the Stanford Center on China's Economy and Institutions
karen-0320_cropprd.jpg PhD

Karen Eggleston is a Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University and Director of the Stanford Asia Health Policy Program at the Shorenstein Asia-Pacific Research Center at FSI. She is also a Fellow with the Center for Innovation in Global Health at Stanford University School of Medicine, and a Faculty Research Fellow of the National Bureau of Economic Research (NBER). Her research focuses on government and market roles in the health sector and Asia health policy, especially in China, India, Japan, and Korea; healthcare productivity; and the economics of the demographic transition.

Eggleston earned her PhD in public policy from Harvard University and has MA degrees in economics and Asian studies from the University of Hawaii and a BA in Asian studies summa cum laude (valedictorian) from Dartmouth College. Eggleston studied in China for two years and was a Fulbright scholar in Korea. She served on the Strategic Technical Advisory Committee for the Asia Pacific Observatory on Health Systems and Policies and has been a consultant to the World Bank, the Asian Development Bank, and the WHO regarding health system reforms in the PRC.

Director of the Asia Health Policy Program, Shorenstein Asia-Pacific Research Center
Stanford Health Policy Associate
Faculty Fellow at the Stanford Center at Peking University, June and August of 2016
CV
Date Label
Karen Eggleston Speaker Stanford University
Seminars
-

In this session of the Shorenstein APARC Corporate Affiliate Visiting Fellows Research Presentations, the following will be presented:

Hiroyuki Koyano, "The Strategy for Accerlation of Patent Examination - Focusing on Human Resource Management"

The number of patent application filings has increased across the world as a result of the globalization of the world economy. In addition, technology has become more complex and the demands for a quality patent has grown. Working against this trend, the period of patent examination has become longer, so patent offices have adopted plans to remedy the situation and accelerate patent examination. Hiroyuki Koyano attempts to compare the United States Patent and Trademark Office’s (USPTO) plans with those of JPO’s and analyze the problems focusing mainly on human resource management.

Mitsue Kurihara, "The Recent M&A Boom in Japan"

Mergers and Acquisitons in Japan have been booming since the late 1990s. What initially started as a method for industrial rehabilitation, today, M&A is put to use by many companies as part of their corporate strategy. Utilizing her experiences as an advisor for M&A, Kurihara researches the remarkable trend in the boom of Japanese M&A over the last ten years, as well as the future of Japanese M&A market in terms of where it should be headed.

Bhavna Sharma, “Polymorphisms in Breast Cancer Mutation Carriers: Comparative Studies in Caucasian and Hong Kong Population”

Breast cancer rates differ significantly in Asia compared to the United States and other western countries.  Lifestyle and genetic differences between these populations are probably causes of this variation.  Sharma presents findings from her study that hypothesized that the genetic breast cancer risk factors that differ between BRCA1/2 mutation carriers in Asia and the U.S. may result in a different magnitude of breast cancer risk among Asians versus Caucasians who carry BRCA1/2 mutations.

Philippines Conference Room

0
Corporate Affiliate Visiting Fellow
Koyano.jpg

Hiroyuki Koyano is a corporate affiliate visiting fellow at Shorenstein APARC for 2008-09. He joined the Japan Patent Office (JPO), government of Japan in 1994 and has worked for JPO as a patent examiner, handling patent applications mainly in the field of construction and housing equipments. In 2003, he was in charge of researching trends on patent applications in the fields of physics, optics and construction. In 2006, he was also assigned to a position where he managed the outsourcing of prior art searches for expediting the examination process. He received his BS in agriculture from the University of Tokyo.

Date Label
Hiroyuki Koyano Corporate Affiliate Visiting Fellow, Japan Patent Office Speaker
0
Corporate Affiliate Visiting Fellow
652666220_TZoHS-L-1.jpg

Mitsue Kurihara is a corporate affiliate visiting fellow at Shorenstein APARC for 2008-09 and 2009-10. Prior to joining Shorenstein APARC, she worked at the Development Bank of Japan (DBJ) for twenty years. She has comprehensive experience in policy-based financing, in addition to having been involved in the merger of Japan Development Bank with Hokkaido-Tohoku Development Finance Public Corporation into DBJ during her term in the Treasury Department. Over the past five years, she has leveraged her wide network of regional bank and enterprise connections to provide advice on various industrial restructuring and other M&A deals. Kurihara’s latest position at the DBJ was as director in the Department for Business Development (in charge of advisory services for mergers, acquisitions, divestitures, and corporate strategy planning). 

Kurihara was also assigned for a time at the Ministry of Education, Culture, Sports, Science and Technology. She graduated from Hitotsubashi University with a BA in law.

Date Label
Mitsue Kurihara Corporate Affiliate Visiting Fellow, Development Bank of Japan Speaker
0
Corporate Affiliate Visiting Fellow
Sharma.jpg

Bhavna Sharma is a corporate affiliate visiting fellow at Shorenstein APARC for 2008-09. Prior to joining Shorenstein APARC, she has been working for Reliance Life Sciences in Navi Mumbai (India), as Laboratory Manager, Molecular Medicine. Her job responsibilities include Laboratory Management - allocation of routine diagnostic tests, review & approval of diagnostic test results, documentation preparation for standard operating procedures, protocol of analysis, test report formats, validation documents, planning for inter/intra -laboratory validation & quality control testing, and organizing plans for training. Sharma is doing her post-graduate work in Microbiology and previously worked in Molecular Medicine at Jaslok Hospital and Research Centre, Laboratory of Cancer Genes at Cancer Research Institute prior to joining Reliance Life Sciences in June 2001.

Date Label
Bhavna Sharma Corporate Affiliate Visiting Fellow, Reliance Industries, India Speaker
Seminars
Subscribe to Globalization